Buscar resultados de ensayos clínicos

Patrocinado por

Choroidal Neovascularization - 17 Studies Found

Estado Estudiar
Completed Nombre del estudio: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial
Condición: Choroidal Neovascularization
Fecha: 2006-08-09
Intervenciones:
  • Drug: Ranibizumab 0.3 mg/0.05

Completed Nombre del estudio: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen
Condición: Choroidal Neovascularisation
Fecha: 2009-12-21
Intervenciones: Drug: ranibizumab 0.5mg
Completed Nombre del estudio: TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Condición: Choroidal Neovascularization
Fecha: 2005-11-29
Intervenciones: Procedure: Photodynamic therapy versus Transpupillary thermotherapy
Completed Nombre del estudio: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
Condición: Myopic Choroidal Neovascularization
Fecha: 2008-11-24
Intervenciones: Drug: Injection Intravitreal injection of 1.25 mg bevacizumab
Withdrawn Nombre del estudio: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Condición: Choroidal Neovascularization
Fecha: 2006-11-22
Intervenciones: Drug: Imatinib Mesylate /Ranibizumab
Completed Nombre del estudio: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.
Condición: Choroidal Neovascularization (CNV)
Fecha: 2013-04-23
Intervenciones:
  • Drug: Ranibizumab Ranibizumab

Completed Nombre del estudio: Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization
Condición: Subfoveal Choroidal Neovascularization
Fecha: 2006-12-01
Intervenciones:
  • Drug: intravitreal injection of ranibizumab
Completed Nombre del estudio: Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condición: Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Fecha: 2013-08-12
Intervenciones:
  • Drug: Ranibizumab 0.5mg 0.5 mg
Completed Nombre del estudio: Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
Condición: Choroidal Neovascularization
Fecha: 2006-11-01
Intervenciones: Drug: ranibizumab 0.5mg intravitreal injection
Completed Nombre del estudio: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Condición:
  • Choroidal Neovascularization
  • Myopia, Degenerative

Fecha: 2011-08-22
Intervenciones: Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/-
Next >>>